(Q63594128)

English

Demonstration of Equivalent Effectiveness of a Novel Anti-allergic Nasal Spray and a Marketed Nasal Product as Well as Demonstration of Fast Symptom Reduction in Allergic Patients

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Demonstration of Therapeutic Equivalence/Non-inferiority as Well as Early Onset of Action of the Novel Water-soluble Budesonide Nasal Spray (Budesolv 10) Compared With Marketed Rhinocort® Aqua 64 in Patients Suffering From Grass Pollen Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Controlled Asthma (English)

0 references

0 references

0 references

0 references

19 November 2018

0 references